Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling

Molecular Biology of the Cell

Volumn 24, Issue 11, 2013, Pages 1812-1824

  Tazat, Keren ^a   Harsat, Meirav ^a   Goldshmid Shagal, Ayelet ^a   Ehrlich, Marcelo ^a   Henis, Yoav I ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PHOSPHOLIPASE D1; PROTEIN; PROTEIN KINASE B; PROTEIN P27; RAL PROTEIN; RALA PROTEIN; RALB PROTEIN; RALBP1 PROTEIN; RAS PROTEIN; SERINE; SHORT HAIRPIN RNA; THREONINE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; GENE SILENCING; GROWTH DISORDER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GTPASE-ACTIVATING PROTEINS; HEK293 CELLS; HUMANS; MICE; MINK; PHOSPHOLIPASE D; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RAL GTP-BINDING PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MURINAE;

EID: 84878686593     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-01-0007     Document Type: Article

References (81)

1. Besson A, Dowdy SF, Roberts JM (2008). CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14, 159-169. (Pubitemid 351189186)
2. Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM (2006). A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev 20, 47-64. (Pubitemid 43042667)
3. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM (2004). p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18, 862-876. (Pubitemid 38529656)
4. Bi K, Roth MG, Ktistakis NT (1997). Phosphatidic acid formation by phospholipase D is required for transport from the endoplasmic reticulum to the Golgi complex. Curr Biol 7, 301-307. (Pubitemid 27195606)
5. Bloom J, Pagano M (2003). Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 13, 41-47. (Pubitemid 36269179)
6. Bodemann BO, White MA (2008). Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat Rev Cancer 8, 133-140. (Pubitemid 351187648)
7. Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG (2002). A growth factor-dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression. EMBO J 21, 3390-3401. (Pubitemid 34760571)
8. Boissel L, Houssin N, Chikh A, Rynditch A, Van Hove L, Moreau J (2007). Recruitment of Cdc42 through the GAP domain of RLIP participates in remodeling of the actin cytoskeleton and is involved in Xenopus gastrulation. Dev Biol 312, 331-343. (Pubitemid 350180760)
9. Bos JL (1989). Ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689. (Pubitemid 19213607)
10. Boucrot E, Saffarian S, Massol R, Kirchhausen T, Ehrlich M (2006). Role of lipids and actin in the formation of clathrin-coated pits. Exp Cell Res 312, 4036-4048. (Pubitemid 44828048)
11. Cantor SB, Urano T, Feig LA (1995). Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol Cell Biol 15, 4578-4584.
12. Chien Y, White MA (2003). RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep 4, 800-806. (Pubitemid 37063189)
13. Chu IM, Hengst L, Slingerland JM (2008). The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8, 253-267. (Pubitemid 351430863)
14. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF (1995). Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92, 5545-5549.
15. Derynck R, Akhurst RJ, Balmain A (2001). TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29, 117-129. (Pubitemid 32952643)
16. Du G, Huang P, Liang BT, Frohman MA (2004). Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol Biol Cell 15, 1024-1030. (Pubitemid 38316213)
17. Emkey R, Freedman S, Feig LA (1991). Characterization of a GTPase-activating protein for the Ras-related Ral protein. J Biol Chem 266, 9703-9706. (Pubitemid 21906713)
18. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM (1993). TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009-1020. (Pubitemid 23289458)
19. Feig LA (2003). Ral-GTPases: approaching their 15 minutes of fame. Trends Cell Biol 13, 419-425. (Pubitemid 36897646)
20. Frohman MA, Sung TC, Morris AJ (1999). Mammalian phospholipase D structure and regulation. Biochim Biophys Acta 1439, 175-186. (Pubitemid 29333130)
21. Goi T, Rusanescu G, Urano T, Feig LA (1999). Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth. Mol Cell Biol 19, 1731-1741. (Pubitemid 29098231)
22. Guo X, Wang XF (2009). Signaling cross-talk between TGF-β/BMP and other pathways. Cell Res 19, 71-88.
23. Hammond SM, Altshuller YM, Sung TC, Rudge SA, Rose K, Engebrecht J, Morris AJ, Frohman MA (1995). Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem 270, 29640-29643. (Pubitemid 26001622)
24. Hannon GJ, Beach D (1994). p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261.
25. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC (1999). Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859-869. (Pubitemid 29446902)
26. Hu PP, Datto MB, Wang XF (1998). Molecular mechanisms of transforming growth factor-β signaling. Endocr Rev 19, 349-363. (Pubitemid 29117820)
27. Iavarone A, Massague J (1997). Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387, 417-422. (Pubitemid 27227208)
28. Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI (2002). Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem 277, 14355-14358. (Pubitemid 34952496)
29. Issaq SH, Lim KH, Counter CM (2010). Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis. Mol Cancer Res 8, 223-231.
30. Jiang H, Lu Z, Luo JQ, Wolfman A, Foster DA (1995). Ras mediates the activation of phospholipase D by v-Src. J Biol Chem 270, 6006-6009.
31. Kashatus DF, Lim KH, Brady DC, Pershing NL, Cox AD, Counter CM (2011). RalA and RalBP1 regulate mitochondrial fission at mitosis. Nat Cell Biol 13, 1108-1115.
32. Kfir S, Ehrlich M, Goldshmid A, Liu X, Kloog Y, Henis YI (2005). Pathway- and expression level-dependent effects of oncogenic N-Ras: p27Kip1 mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Mol Cell Biol 25, 8239-8250. (Pubitemid 41263014)
33. Klein J (2005). Functions and pathophysiological roles of phospholipase D in the brain. J Neurochem 94, 1473-1487. (Pubitemid 41324632)
34. Leake K, Singhal J, Nagaprashantha LD, Awasthi S, Singhal SS (2012). RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer. PLoS One 7, e34582.
35. Lehmann K, Janda E, Pierreux CE, Rytomaa M, Schulze A, McMahon M, Hill CS, Beug H, Downward J (2000). Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev 14, 2610-2622.
36. Liang J et al. (2002). PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8, 1153-1160. (Pubitemid 35175971)
37. Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD, Der CJ, Counter CM (2005). Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7, 533-545. (Pubitemid 40799247)
38. Lim KH, Brady DC, Kashatus DF, Ancrile BB, Der CJ, Cox AD, Counter CM (2010). Aurora-A phosphorylates, activates and relocalizes the small GTPase RalA. Mol Cell Biol 30, 508-523.
39. Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ, Counter CM (2006). Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol 16, 2385-2394. (Pubitemid 44894905)
40. Liu X, Sun Y, Ehrlich M, Lu T, Kloog Y, Weinberg RA, Lodish HF, Henis YI (2000). Disruption of TGF-β growth inhibition by oncogenic Ras is linked to p27Kip1 mislocalization. Oncogene 19, 5926-5935. (Pubitemid 32005374)
41. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25, 402-408. (Pubitemid 34164012)
42. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M (1997). Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3, 231-234. (Pubitemid 27064711)
43. Luo JQ, Liu X, Hammond SM, Colley WC, Feig LA, Frohman MA, Morris AJ, Foster DA (1997). RalA interacts directly with the Arf-responsive, PIP2-dependent phospholipase D1. Biochem Biophys Res Commun 235, 854-859. (Pubitemid 27326574)
44. Martin TD, Samuel JC, Routh ED, Der CJ, Yeh JJ (2011). Activation and involvement of Ral GTPases in colorectal cancer. Cancer Res 71, 206-215.
45. Martina JA, Chen Y, Gucek M, Puertollano R (2012). MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8, 903-914.
46. Min DS et al. (2001). Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 22, 1641-1647. (Pubitemid 32952141)
47. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M (1999). Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 13, 1181-1189. (Pubitemid 29233148)
48. Moskalenko S, Henry DO, Rosse C, Mirey G, Camonis JH, White MA (2002). The exocyst is a Ral effector complex. Nat Cell Biol 4, 66-72. (Pubitemid 34071982)
49. Moskalenko S, Tong C, Rosse C, Mirey G, Formstecher E, Daviet L, Camonis J, White MA (2003). Ral GTPases regulate exocyst assembly through dual subunit interactions. J Biol Chem 278, 51743-51748. (Pubitemid 38020420)
50. Nakashima S, Nozawa Y (1999). Possible role of phospholipase D in cellular differentiation and apoptosis. Chem Phys Lipids 98, 153-164. (Pubitemid 29150403)
51. Oft M, Akhurst RJ, Balmain A (2002). Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 4, 487-494. (Pubitemid 34752433)
52. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E (1996). TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10, 2462-2477. (Pubitemid 26341881)
53. Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC, Theodorescu D (2005). RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res 65, 7111-7120. (Pubitemid 41161240)
54. Pagano M, Tam SW, Theodoras AM, Beer Romero P, Del Sal G, Chau V, Renee Yew P, Draetta GF, Rolfe M (1995). Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685.
55. Pelish HE, Peterson JR, Salvarezza SB, Rodriguez-Boulan E, Chen JL, Stamnes M, Macia E, Feng Y, Shair MD, Kirchhausen T (2006). Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro. Nat Chem Biol 2, 39-46.
56. Pietenpol JA, Holt JT, Stein RW, Moses HL (1990). Transforming growth factor β1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87, 3758-3762.
57. Reynisdottir I, Massague J (1997). The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 11, 492-503. (Pubitemid 27097647)
58. Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S (2001). p27 cytoplasmic localization is regulated by phosphorylation on Ser-10 and is not a prerequisite for its proteolysis. EMBO J 20, 6672-6682. (Pubitemid 33134197)
59. Rosse C, Hatzoglou A, Parrini MC, White MA, Chavrier P, Camonis J (2006). RalB mobilizes the exocyst to drive cell migration. Mol Cell Biol 26, 727-734. (Pubitemid 43089782)
60. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ (2008). Rac activation and inactivation control plasticity of tumor cell movement. Cell 135, 510-523.
61. Schmierer B, Hill CS (2007). TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8, 970-982. (Pubitemid 350174642)
62. Shalom-Feuerstein R, Levy R, Makovski V, Raz A, Kloog Y (2008). Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras. Biochim Biophys Acta 1783, 985-993.
63. Shapira KE, Gross A, Ehrlich M, Henis YI (2012). Coated pit-mediated endocytosis of the type I transforming growth factor-β (TGF-β) receptor depends on a di-leucine family signal and is not required for signaling. J Biol Chem 287, 26876-26889.
64. Sherr CJ, Roberts JM (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13, 1501-1512. (Pubitemid 29297917)
65. Shi Y, Massague J (2003). Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700. (Pubitemid 36724933)
66. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL (2002). PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization. Nat Med 8, 1145-1152. (Pubitemid 35175970)
67. Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, Awasthi S (2007). Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res 67, 4382-4389. (Pubitemid 46815087)
68. Sung TC, Roper RL, Zhang Y, Rudge SA, Temel R, Hammond SM, Morris AJ, Moss B, Engebrecht J, Frohman MA (1997). Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J 16, 4519-4530. (Pubitemid 27326589)
69. Tsubari M, Taipale J, Tiihonen E, Keski Oja J, Laiho M (1999). Hepatocyte growth factor releases mink epithelial cells from transforming growth factor β1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity. Mol Cell Biol 19, 3654-3663. (Pubitemid 29193825)
70. Tsukamoto S, Sugio K, Sakada T, Ushijima C, Yamazaki K, Sugimachi K (2001). Reduced expression of cell-cycle regulator p27Kip1 correlates with a shortened survival in non-small cell lung cancer. Lung Cancer 34, 83-90. (Pubitemid 32824127)
71. Ungermannova D, Gao Y, Liu X (2005). Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2. J Biol Chem 280, 30301-30309. (Pubitemid 41216210)
72. van Dam EM, Robinson PJ (2006). Ral: mediator of membrane trafficking. Int J Biochem Cell Biol 38, 1841-1847. (Pubitemid 44425246)
73. Viglietto G et al. (2002). Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8, 1136-1144. (Pubitemid 35175969)
74. Vlach J, Hennecke S, Amati B (1997). Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 16, 5334-5344. (Pubitemid 27380141)
75. Wander SA, Zhao D, Slingerland JM (2011). p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res 17, 12-18.
76. Wolfman JC, Palmby T, Der CJ, Wolfman A (2002). Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol Cell Biol 22, 1589-1606. (Pubitemid 34150794)
77. Wrana JL, Attisano L, Carcamo J, Zentella A, Doodey J, Laiho M, Wang X-F, Massague J (1992). TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
78. Wu Z, Owens C, Chandra N, Popovic K, Conaway M, Theodorescu D (2010). RalBP1 is necessary for metastasis of human cancer cell lines. Neoplasia 12, 1003-1012.
79. Xu B, Pelish H, Kirchhausen T, Hammond GB (2006). Large scale synthesis of the Cdc42 inhibitor secramine A and its inhibition of cell spreading. Org Biomol Chem 4, 4149-4157. (Pubitemid 44665187)
80. Yoon MS, Chen J (2008). PLD regulates myoblast differentiation through the mTOR-IGF2 pathway. J Cell Sci 121, 282-289. (Pubitemid 351356699)
81. Zeniou-Meyer M et al. (2007). Phospholipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large dense-core granules at a late stage. J Biol Chem 282, 21746-21757. (Pubitemid 47195770)